Thomas X - Search Results

1

Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis and/or at first relapse: results from the GET-LALA group.

Reman O, Pigneux A, Huguet F, Vey N, Delannoy A, Fegueux N, de Botton S, Stamatoullas A, Tournilhac O, Buzyn A, Charrin C, Boucheix C, Gabert J, Lhéritier V, Vernant JP, Fière D, Dombret H, Thomas X; GET-LALA group. Reman O, et al. Among authors: thomas x. Leuk Res. 2008 Nov;32(11):1741-50. doi: 10.1016/j.leukres.2008.04.011. Epub 2008 May 27. Leuk Res. 2008. PMID: 18508120

2

Expression of surface adhesion molecules CD54 (ICAM-1) and CD58 (LFA-3) in adult acute leukemia: relationship with initial characteristics and prognosis.

Archimbaud E, Thomas X, Campos L, Magaud JP, Doré JF, Fiere D. Archimbaud E, et al. Among authors: thomas x. Leukemia. 1992 Apr;6(4):265-71. Leukemia. 1992. PMID: 1375302

3

Susceptibility of acute myelogenous leukemia blasts to lysis by lymphokine-activated killer (LAK) cells and its clinical relevance.

Archimbaud E, Thomas X, Campos L, Fiere D, Doré JF. Archimbaud E, et al. Among authors: thomas x. Leuk Res. 1992 Jun-Jul;16(6-7):673-80. doi: 10.1016/0145-2126(92)90018-3. Leuk Res. 1992. PMID: 1378919

4

Surface marker expression in acute myeloid leukaemia at first relapse.

Thomas X, Campos L, Archimbaud E, Shi ZH, Treille-Ritouet D, Anglaret B, Fiere D. Thomas X, et al. Br J Haematol. 1992 May;81(1):40-4. doi: 10.1111/j.1365-2141.1992.tb08168.x. Br J Haematol. 1992. PMID: 1381608

5

Maintenance with low-dose cytarabine for acute myeloid leukemia in complete remission.

Archimbaud E, Anglaret B, Thomas X, Jaubert J, Sebban C, Guyotat D, Fiere D. Archimbaud E, et al. Among authors: thomas x. Ann Hematol. 1992 Aug;65(2):71-4. doi: 10.1007/BF01698132. Ann Hematol. 1992. PMID: 1511060 Clinical Trial.

6

Continuous-infusion daunorubicin and carboplatin for high-risk acute myeloid leukemia in the elderly.

Archimbaud E, Anglaret B, Thomas X, Devaux Y, Ffrench M, Sebban C, Troncy J, Fiere D. Archimbaud E, et al. Among authors: thomas x. Leukemia. 1992 Aug;6(8):776-9. Leukemia. 1992. PMID: 1640728

7

In vitro effects of recombinant hemopoietic growth factors on progenitor cells from patients with myelodysplastic syndromes.

Thomas X, Guyotat D, Campos L, Shi ZH, Vila L, Ehrsam A, Fiere D. Thomas X, et al. Leuk Res. 1991;15(1):29-36. doi: 10.1016/0145-2126(91)90141-f. Leuk Res. 1991. PMID: 1705306

8

High risk myelodysplastic syndrome coexistent with chronic lymphocytic leukemia for more than 9 years: inhibition of the myeloid clone by the lymphoid clone?

Bastion Y, Thomas X, Felman P, Campos L, Charrin C, Coiffier B. Bastion Y, et al. Among authors: thomas x. Leukemia. 1991 Nov;5(11):1006-9. Leukemia. 1991. PMID: 1961029

9

Susceptibility of adult acute lymphoblastic leukemia blasts to lysis by lymphokine-activated killer cells.

Archimbaud E, Thomas X, Campos L, Magaud JP, Fiere D, Doré JF. Archimbaud E, et al. Among authors: thomas x. Leukemia. 1991 Nov;5(11):967-71. Leukemia. 1991. PMID: 1961038

10

Antiemetic activity of high-dose methylprednisolone associated with continuous-infusion metoclopramide and oral alprazolam during multiple-day chemotherapy.

Salles G, Archimbaud E, Thomas X, Fiere D. Salles G, et al. Among authors: thomas x. Cancer Chemother Pharmacol. 1991;28(1):77-9. doi: 10.1007/BF00684962. Cancer Chemother Pharmacol. 1991. PMID: 2040038 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

448 results

Search Page

Filters